Evidence map›Paper›PMID 39961160›Full record

ArticleDrug and alcohol dependence2025

Influence of insurance type on healthcare utilization among rural people who use drugs.

W D Jenkins, M T Pho, R M Nance, A M Young, W Zule, T J Stopka, P D Friedmann, W C Miller, V F Go, P T Korthuis and 8 more

Abstract read
In one paragraph

Article in Drug and alcohol dependence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

W D JenkinsDepartment of Public Health Sciences, Clemson University, 535-A Edwards Hall, 201 Epsilon Zeta Drive, Clemson, SC 29634, United States. Electronic address: wileyj@clemson.edu.
M T PhoDepartment of Medicine, Section of Infectious Diseases & Global Health, University of Chicago Medicine, 5481 S Maryland Ave, Chicago, IL 60637, United States.
R M NanceDivision of Infectious Diseases, University of Washington, Harborview Medical Center, 325 9th Ave, Box 359931, Seattle, WA 908104, United States.
A M YoungDepartment of Epidemiology and Environmental Health, University of Kentucky, 111 Washington Avenue, Lexington, KY 40536, United States.
W Zule503 Scotney Circle, Durham, NC 27713, United States.
T J StopkaDepartment of Public Health and Community Medicine, Tufts University School of Medicine, 136 Harrison Ave, Boston, MA 02111, United States.
P D FriedmannMPH. Office of Research. Baystate Health and University of Massachusetts Chan Medical School-Baystate, 3601 Main Street, Room 327, Springfield, MA 011077, United States.
W C MillerDepartment of Epidemiology, UNC Gillings School of Global Public Health, Chapel Hill, NC, United States.
V F GoDepartment of Health Behavior, UNC Gillings School of Global Public Health, 363 Rosenau Hall, Chapel Hill, NC 27599-7440, United States.
P T KorthuisDepartment of Medicine, Section of Addiction Medicine, 3181 SW Sam Jackson Park Rd, Portland, OR 97239-3098, United States.
R WestergaardDepartment of Medicine, University of Wisconsin School of Medicine and Public Health, 610 Walnut St, Madison, WI 53726, United States.
D W SealDepartment of Social, Behavioral, and Population Sciences, Tulane University School of Public Health and Tropical Medicine, New Orleans, LA 70112, United States.
J FeinbergDepartments of Behavioral Medicine and Psychiatry & Medicine/Infectious Diseases, West Virginia University School of Medicine, 930 Chestnut Ridge Rd, Morgantown, WV 26505, United States.
G S SmithStuart M. and Joyce N. Robbins Distinguished Professor, Department of Epidemiology and Biostatistics, School of Public Health, West Virginia University, PO Box 9190, Morgantown, WV 26506-9190, United States.
H M CraneDivision of Infectious Diseases, University of Washington, Harborview Medical Center, 325 9th Ave, Box 359931, Seattle, WA 908104, United States.
J I TsuiDepartment of Medicine, University of Washington, Harborview Medical Center, 325 9th Ave, Seattle, WA 98104, United States.
T LanterSIU School of Medicine, 801 N Rutledge St, Springfield, IL 62702, United States.
V ChoudharyDepartment of Population Science and Policy, SIU School of Medicine, 201 E. Madison Street, Springfield, IL 62794-9664, United States.

Funding

University of Washington/Fred Hutch Center for AIDS ResearchP30AI027757 · NIAID · UNIVERSITY OF WASHINGTON · PI Kenneth Sherr · 1988 to 2026
$104.9M
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)UL1TR002369 · NCATS · OREGON HEALTH & SCIENCE UNIVERSITY · PI Cynthia D Morris, Christopher G. Slatore · 2017 to 2026
$78.4M
Ending transmission of HIV, HCV, and STDs and overdose in rural communities of people who inject drugs (ETHIC)UH3DA044829 · NIDA · UNIVERSITY OF CHICAGO · PI JENKINS, WILEY, PHO, MAI TUYET · 2019 to 2022
$5.2M
Kentucky Communities and Researchers Engaging to Halt the Opioid Epidemic (CARE2HOPE)UH3DA044798 · NIDA · UNIVERSITY OF KENTUCKY · PI COOPER, HANNAH LF, YOUNG, APRIL MARIE · 2019 to 2022
$4.4M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study Cost ExtensionUH3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2019 to 2022
$4.0M
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)UH3DA044830 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI FRIEDMANN, PETER D, STOPKA, THOMAS J · 2019 to 2022
$3.9M
Rural Comorbidity and HIV consequences of Opioid use Research and Treatment Initiative (Rural cohort)U24DA048538 · NIDA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., TSUI, JUDITH · 2019 to 2023
$3.7M
Next-Generation Sequencing Center for GHOSTing Hepatitis C Virus: Transforming Community Based Molecular Surveillance and Outbreak InvestigationU24DA044801 · NIDA · MASSACHUSETTS GENERAL HOSPITAL · PI ALLEN, TODD M · 2017 to 2022
$3.3M
Community-based, client-centered prevention homes to address the rural opioid epidemicUH3DA044826 · NIDA · UNIVERSITY OF WISCONSIN-MADISON · PI SEAL, DAVID W, WESTERGAARD, RYAN PATRICK · 2019 to 2022
$2.6M
Learning from the COVID-19 pandemic to improve emergency management planning for harm reduction services in rural OhioUH3DA044822 · NIDA · OHIO STATE UNIVERSITY · PI GO, VIVIAN F., MILLER, WILLIAM C · 2019 to 2022
$2.5M
Mitigating the Outcomes Associated with the Injection Drug Use Epidemic in Southern AppalachiaUH3DA044823 · NIDA · RESEARCH TRIANGLE INSTITUTE · PI ZULE, WILLIAM A · 2019 to 2021
$2.4M
Drug Injection Surveillance and Care Enhancement for Rural Northern New England (DISCERNNE)UG3DA044830 · NIDA · BAYSTATE MEDICAL CENTER, INC. · PI FRIEDMANN, PETER D · 2017 to 2018
$1.6M
NCATS NIH HHS UL1 TR002369NIAID NIH HHS P30 AI027757NIDA NIH HHS U24 DA044801NIDA NIH HHS U24 DA048538NIDA NIH HHS UG3 DA044798NIDA NIH HHS UG3 DA044822NIDA NIH HHS UG3 DA044823NIDA NIH HHS UG3 DA044825NIDA NIH HHS UG3 DA044826NIDA NIH HHS UG3 DA044829NIDA NIH HHS UG3 DA044830NIDA NIH HHS UG3 DA044831NIDA NIH HHS UH3 DA044798NIDA NIH HHS UH3 DA044822NIDA NIH HHS UH3 DA044823NIDA NIH HHS UH3 DA044826NIDA NIH HHS UH3 DA044829NIDA NIH HHS UH3 DA044830NIDA NIH HHS UH3 DA044831
6 · The paper itself

Abstract

backgroundInsurance possession facilitates healthcare engagement. Though people who use drugs (PWUD) experience substantial health risks, a large proportion are un/underinsured. Medicaid/other insurance eligibility varies by state and criminal legal involvement (CLI), and a better understanding of their association is important to inform policy.

methodsParticipants in the Rural Opioid Initiative were recruited 2018-2020 across 10 states and completed surveys assessing their demographics and insurance status, CLI experiences, substance use-related healthcare utilization, and healthcare barriers and venues. Descriptive analyses examined these factors versus insurance status and were followed by multivariable regression to include Medicaid expansion state residence.

resultsThe 2933 participants had a mean age of 36 years [s.d.= 10.3]; were 85 % White, 3.2 % Black, and 7.1 % Native American; and were 57.0 % men. Insurance status was categorized as none (23.9 %), Medicaid (60.0 %), and other (16.2 %). Reporting stop/search, arrest or jail correlated with a significant reduction in the proportion of persons with Medicaid insurance (all p < 0.001). Having ever received HCV/HIV screening, and eight types of substance use disorder treatment, were more common among Medicaid versus uninsured individuals (p ≤ 0.001). Medicaid insured individuals more frequently reported obtaining care at a private venue, and less frequently reported having no care (past 6-months) or care barriers (p < 0.001)

conclusionLack of insurance among rural PWUD was associated with CLI, reduced healthcare utilization, and greater care barriers. Medicaid coverage facilitates national-level guideline promulgation regarding healthcare access of individuals experiencing increased health risks. Links between Medicaid expansion and CLI indicate opportunities to better coordinate services.

Indexed as

Drug UsersInsurance CoverageInsurance, HealthPatient Acceptance of Health CareRural PopulationSubstance-Related DisordersAdultFemaleHealth Services AccessibilityHumansMaleMedicaidMiddle AgedUnited StatesCriminal legal involvementHealthcareInsurance statusPeople who use drugsRural

Identifiers

PMID39961160
PMCPMC12020429

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.